flumazenil (Romazicon, Mazicon)
Jump to navigation
Jump to search
Introduction
Tradenames: Mazicon, Romazicon.
Indications
- benzodiazepine sedation reversal:
- benzodiazepine overdose reversal:
* Note: 1/2 life 40-80 minutes is considerably less than that of most benzodiazepines
Contraindications
- patients with serious signs of tricyclic antidepressant overdose
- patients given benzodiazepines for control of potentially life-threatening conditions
- status epilepticus
- control of intracranial pressure
Pharmacokinetics
- rapidly inactivated by the liver by hydroxylation
- 1/2life is 1 hour
- reversal of benzodiazepine may take effect in 1-3 minutes & last 1-5 hours
elimination via liver
elimination via kidney
1/2life = 40-80 minutes
Adverse effects
- common (> 10%)
- less common (1-10%)
- headache, pain at injection site, increased sweating, asthenia, malaise, hot flashes, anxiety, nervousness, dry mouth, tremor, insomnia, dyspnea, hyperventilation, abnormal crying, euphoria, depression, vision disorders
- uncommon (< 1%)
- shivering, hearing disorder, bradycardia, tachycardia, chest pain, hypertension, variations in blood pressure, hiccups, somnolence, thick tongue, ventricular asystoles, anxiety, sensation of coldness, generalized convulsions*, withdrawal syndrome
- other[4]
- may precipitate seizures*
- resedation may occur
* Be prepared to manage seizures prior to administration.
Drug interactions
- toxic effects of tricyclic antidepressant overdose may emerge with reversal of benzodiazepine effect
Mechanism of action
- competitively antagonizes the effects of benzodiazepines on GABA-mediated inhibitory pathways in the CNS
More general terms
Additional terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ 4.0 4.1 Seger DL. Flumazenil--treatment or toxin. J Toxicol Clin Toxicol 2004; 42:209 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15214628
- ↑ An H, Godwin J. Flumazenil in benzodiazepine overdose. CMAJ. 2016 Dec 6;188(17-18):E537. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27920113 Free PMC Article
- ↑ Department of Veterans Affairs, VA National Formulary